Emtricitabine
Material: | Dried capillary blood Mitra-collection system (20 µL) |
Methods: | Flüssigkeitschromatographie-Massenspektrometrie (LC-MS/MS) → LC-Tandem-Massenspektrometrie | Reference range | Emtricitabine is a prodrug, which is only transformed into its active metabolite intracellularly. Therefore, no sensible therapeutic range can be given.
For the control of adherence to therapy however, there are pharmacological expectancy levels in serum/plasma: In case of standard dose, the following levels can be found in the serum: 2 hours after administration: approximately 1500 µg/l 12 hours after administration: approximately 120 µg/l Biological half-life approximately 10 hours |
Indication | Control of adherence to therapy |
Accredited | ja |